PRESS RELEASES Clear Filters March 14, 2025 Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease Read More March 6, 2025 Gain Therapeutics Announces Oral Presentation at AD/PD 2025 Read More February 6, 2025 Gain Therapeutics CEO Gene Mack Issues Letter To Shareholders and Provides Operational Update Read More February 5, 2025 Gain Therapeutics To Participate in Upcoming Investor Conferences Read More January 8, 2025 Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287 Read More January 7, 2025 Gain Therapeutics Appoints Gene Mack as Chief Executive Officer and Director Read More View More IN THE NEWS Clear Filters February 14, 2025 Q&A: Gain Therapeutics CEO Discusses AI-Driven Drug Discovery, Strategic Growth Plans https://www.pharmexec.com/view/gain-therapeutics-ceo-discuss-ai-driven-drug-discovery-strategic-growth-plans Read More January 30, 2025 Takeda makes waves again with CEO pick https://www.biocentury.com/article/654892/takeda-makes-waves-again-with-ceo-pick Read More January 20, 2025 Scrip Asks… What Does 2025 Hold For Biopharma? Part 3: Impacts Of Political Change In US And Beyond https://insights.citeline.com/scrip/scrip-asks/scrip-asks-what-does-2025-hold-for-biopharma-part-3-impacts-of-political-change-in-us-and-beyond-CKTDR3BC2JBU5O6MUHDAKXGXHU/ Read More January 13, 2025 Clinical advisory board launched to boost GT-02287 development https://parkinsonsnewstoday.com/news/clinical-advisory-board-launched-boost-development-gt-02287-parkinsons/ Read More January 10, 2025 John Maraganore turns to ex-Alnylam colleague to lead his latest RNAi bet; Amylyx names commercial chief https://endpts.com/john-maraganore-turns-to-ex-alnylam-colleague-to-lead-his-latest-rnai-bet-amylyx-names-commercial-chief/ Read More January 9, 2025 Gain Therapeutics Appoints Gene Mack As CEO And Director https://pulse2.com/gain-therapeutics-appoints-gene-mack-as-ceo-and-director/ Read More View More EVENTS Clear Filters March 17, 2025 ROTH Fireside Chat with President & CEO Gene Mack Read More August 8, 2024 BTIG Fireside Chat with Interim CEO Gene Mack and CMO Jonas Hannestad – Virtual Biotechnology Conference 2024 Read More June 27, 2024 H.C. Wainwright Fireside Chat with Gene Mack – 5th Annual Neuro Perspectives Virtual Conference Read More June 27, 2024 Business and Corporate Update Call with interim-CEO Gene Mack Read More March 19, 2024 Public Ventures Discovery Day with Eric Richman Read More February 15, 2024 Gain Therapeutics’ 2024 R&D update with KOL and Analyst Insight Read More View More
